购物车
  • TargetMol
    您的购物车当前为空

Lersivirine

一键复制产品信息
Rating icon 很棒

纯度: 98.01%

货号 T7700Cas号 473921-12-9

别名 UK-453061, Lersivirine(UK 453061), 3-氰基-5-[[3,5-二乙基-1-(2-羟基乙基)-1H-吡唑-4-基]氧基]苯腈

Lersivirine (UK-453061) 是非核苷逆转录的抑制剂 (NNRTI),有效抑制 NNRTI 耐药病毒。它对野生型人类免疫缺陷病毒和临床相关 NNRTI 耐药菌株显示出强大的抗逆转录病毒活性。

Lersivirine
TargetMol

为众多的药物研发团队赋能,

让新药发现更简单!

Lersivirine

一键复制产品信息
Rating icon 很棒

纯度: 98.01%

货号 T7700 别名 UK-453061, Lersivirine(UK 453061), 3-氰基-5-[[3,5-二乙基-1-(2-羟基乙基)-1H-吡唑-4-基]氧基]苯腈Cas号 473921-12-9

Lersivirine (UK-453061) 是非核苷逆转录的抑制剂 (NNRTI),有效抑制 NNRTI 耐药病毒。它对野生型人类免疫缺陷病毒和临床相关 NNRTI 耐药菌株显示出强大的抗逆转录病毒活性。

规格价格库存数量
1 mg
¥ 143
现货
5 mg
¥ 342
现货
10 mg
¥ 541
现货
25 mg
¥ 1,070
现货
50 mg
¥ 1,620
现货
100 mg
¥ 2,310
现货
200 mg
¥ 3,230
现货
1 mL x 10 mM (in DMSO)
¥ 376
现货
库存状态实时更新,以官网显示为准,现货产品可直接加购物车下单
大包装 & 定制
加入购物车
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
实验操作小课堂
常见问题解答
查看更多
选择批次:
纯度: 98.01%
联系我们 获取更多批次信息

产品介绍


Lersivirine AI Summary
Lersivirine exhibits significant antiviral activity against HIV with IC50 values of 4.0 nM and 119.0 nM in different assays. It targets multiple HIV reverse transcriptase mutants with IC95 values ranging from 40.0 nM to 100.0 nM and shows an ability to inhibit both non-competitively and competitively. The compound has low cytotoxicity toward human cells with CC30 values above 30.0 µM, and CC50 values greater than 100,000 nM in certain assays, indicating a high selectivity index. It maintains metabolic stability with a half-life of 1.217 hours in human liver microsomes and demonstrates a half-life of approximately 6.223 hours in healthy human plasma. Pharmacokinetic data shows a peak plasma concentration (Cmax) of about 4910.43 nM and an area under the curve (AUC) of 10967.32 ng.hr.mL-1. Additionally, coadministration with an antacid affects its Tmax, which is 5.0 hours compared to 2.0 hours when administered alone. Moreover, Lersivirine exhibits activity against other viral infections, including SARS-CoV-2, showing cytotoxicity inhibition in Caco-2 and VERO-6 cells at a concentration of 10 µM. It also shows inhibition percentages against SARS-CoV-2 3CL-Pro protease at 20 µM. The compound demonstrates inhibitory activity against the human HDAC6 enzyme and induces the activity of CYP3A, influencing midazolam metabolism. In addition to its antiviral properties, Lersivirine shows antitrypanocidal activity against Trypanosoma brucei and antileishmanial and antiplasmodial activities, albeit with IC50 values indicating low potency in these assays. Overall, Lersivirine presents a broad spectrum of bioactivities with notable efficacy against HIV and potential applications against other viral infections and parasitic diseases..
Note: Summary generated by AI. Data source: ChEMBL
生物活性
产品描述
Lersivirine (UK-453061)(UK 453061) is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) under development for HIV infection therapy.
靶点活性
NNRT:119 nM (IC50)
别名UK-453061, Lersivirine(UK 453061), 3-氰基-5-[[3,5-二乙基-1-(2-羟基乙基)-1H-吡唑-4-基]氧基]苯腈
化学信息
分子量310.35
分子式C17H18N4O2
CAS No.473921-12-9
SmilesCCc1nn(CCO)c(CC)c1Oc1cc(cc(c1)C#N)C#N
密度1.19
储存&溶解度
存储Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
溶解度信息
DMSO: 50 mg/mL (161.11 mM), Sonication is recommended.
体内实验配方
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2.5 mg/mL (8.06 mM), Sonication is recommended.
请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。
溶液配制表
DMSO
1mg5mg10mg50mg
1 mM3.2222 mL16.1108 mL32.2217 mL161.1084 mL
5 mM0.6444 mL3.2222 mL6.4443 mL32.2217 mL
10 mM0.3222 mL1.6111 mL3.2222 mL16.1108 mL
20 mM0.1611 mL0.8055 mL1.6111 mL8.0554 mL
50 mM0.0644 mL0.3222 mL0.6444 mL3.2222 mL
100 mM0.0322 mL0.1611 mL0.3222 mL1.6111 mL

计算器

  • 摩尔浓度 计算器
  • 稀释 计算器
  • 配液 计算器
  • 分子量 计算器

体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:
TargetMol | Animal experiments 比如您的给药剂量是10 mg/kg,每只动物体重20g,给药体积100 μLTargetMol | Animal experiments 一共给药动物10只,您使用的配方为5%TargetMol | reagent DMSO + 30%PEG300 + 5%Tween 80 + 60%Saline/PBS/ddH2O, 那么您的工作液浓度为2mg/mL
母液配置方法: 2 mg 药物溶于 50 μLDMSOTargetMol | reagent ( 母液浓度为 40 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:50μLDMSOTargetMol | reagent 母液,添加 300 μLPEG300TargetMol | reagent 混匀澄清,再加 50μLTween80, 混匀澄清,再加 600μLSaline/PBS/ddH2OTargetMol | reagent 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSOPEG300 / PEG400Tween 80SBE-β-CD玉米油 等, 均可在TargetMol网站点击购买。
1 请输入动物实验的基本信息
mg/kg
g
μL
2 请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

剂量转换

对于不同动物的给药剂量换算,您也可以参考 更多

Related Tags: buy Lersivirine | purchase Lersivirine | Lersivirine cost | order Lersivirine | Lersivirine chemical structure | Lersivirine formula | Lersivirine molecular weight